X T L Biopharmaceuticals reported $138K in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Bioline Rx USD 9.07M 2.31M Mar/2026
Teva Pharmaceutical Industries USD 17.09B 21M Dec/2025
X T L Biopharmaceuticals USD 138K 30K Dec/2024